Best Biopharma Outsourcing Companies in Baden Wurttemberg, Germany
The 33 best Biopharma Outsourcing companies in Baden Wurttemberg, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Cellca.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Baden Wurttemberg
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cellca Specialty company that develops protein-specific cell lines and upstream processes in mammalian cells | $11M | 245 mo ago | Acquired | Hugo De Wit CEO | 2005 | — | 27 patents Optimized mammalian cell culture media formulations and serum‑free cultivation methods | — |
| 2 | ProtaGene Provider of drug development services for cell & gene therapeutic services | $5M | 156 mo ago | Series B | — | 2004 | WordPressMySQLPHP+26 | — | — |
| 3 | Signatope Toxicity testing, ADME studies, assay and antibody development services | $674K | 65 mo ago | Seed | — | 2016 | — | — | — |
| 4 | CeGaT Provider of drug research and development services to develop genetic causes of rare diseases | $109K | 129 mo ago | Funding Raised | — | 2002 | WordPressMySQLPHP+23 | — | — |
| 5 | Trenzyme CRO offering gene synthesis, recombinant protein production and customized cell line development services | $31K | 88 mo ago | Funding Raised | — | 2000 | WordPressMySQLPHP+23 | 6 patents Patents concentrated in health & consumer products | — |
| 6 | Actome Provider of interactome technology intended for biological quantification of proteins | — | 52 mo ago | Seed | Attila Karsai Co-Founder | 2016 | DrupalPHPApache HTTP Server+7 | 24 patents Patents concentrated in computing, sensing & instrumentation | — |
| 7 | CU Chemie Uetikon Manufactures and distributes organic chemicals and pharma APIs | — | 90 mo ago | Acquired | — | 1970 | — | — | — |
| 8 | Rentschler Biopharma Full-service CDMO for biopharmaceuticals | — | 141 mo ago | Funding Raised | — | 1927 | Apple iCloud MailMicrosoft 365Twitch Player+12 | 3 patents Syringe sealing devices and methods for pharmaceutical delivery systems | — |
Top 10 Biopharma Outsourcing companies in Baden Wurttemberg
#1
Seed · Reutlingen, Baden Wurttemberg · founded 2016 · 11 employees$673.7Kraised▾
Signatope specialises in the development of protein biomarker assays using mass spectrometry based immunoassays (Ex: ImmunoMALDI). They are capable of developing immunoassays which can detect protein biomarkers in humans and all physiologically relevant species. Their services for the pharma and CRO industries include kidney and liver toxicity testing services, CYP 450 and transporter assays, drug interaction studies, and custom assay (mainly immunoassays) and antibody development services. They claim to have developed 150+ proprietary antibodies. The company is hosted at the Natural and Medical Sciences Institute at the University of Tubingen.
- Jun 2021Grant (prize money)$733.2K
- May 2017Seed$673.7K
#2
Acquired · Laupheim, Baden Wurttemberg · founded 2005 · 30 employees$11.1Mraised▾
Cellca specializes in biopharmaceutical production in mammalian cells specifically for the industrial production environment. Its technology platform contains four different components: Expression System, Host Cell Line, Media System and Scale-up process. Cellca has partnered with GE Healthcare Bio-Sciences and Rentschler Biotechnology to develop its solutions. Sartorius Stedim Biotech acquired Cellca in 2015.
- May 2006PE$11.1M
#3
Series B · Heilbronn, Baden Wurttemberg · founded 2004 · 55 employees$4.6Mraised▾
Provider of drug development services for cell & gene therapeutic services
- Oct 2013Series B$3.8M
- Aug 2012Seed$857.6K
#4
Funding Raised · Konstanz, Baden Wurttemberg · founded 2000$31.5Kraised▾
Trenzyme is a CRO offering molecular biology, custom protein synthesis and purification and customised cell line development services. As part of its molecular biology services, the major offerings are gene synthesis, DNA cloning and mutagenesis. As part of the protein services, they offer exact proteins post purification from microbial, yeast and mammalian expression systems. Their protein yields protein yields range from a few to several hundred mg. As part of their cell line development services, their proprietary ExoIN, ExoINDUCE, and EndoOUT cell culture processes help in assay cell line and production cell line development. They claim to be capable of developing any cellular system as per exact customer requirements through their proprietary cell culture processes. Roche, Lonza and Biocon are some of their reputed customers.
- Jun 2019Grant (prize money)$31.5K
#5
Funding Raised · Tubingen, Baden Wurttemberg · founded 2002 · 113 employees$108.6Kraised▾
Provider of drug research and development services to develop genetic causes of rare diseases
- Jan 2016Grant (prize money)$108.6K
#6
Seed · Freiburg im Breisgau, Baden Wurttemberg · founded 2016 · 9 employees—raised▾
Provider of interactome technology intended for biological quantification of proteins
- 2022Grant (prize money)—
- Jul 2021Seed—
#7
Acquired · Lahr, Baden Wurttemberg · founded 1970 · 158 employees—raised▾
CU Chemie Uetikon, acquired by the Novacap group in 2015, provides manufactures fine chemical intermediates, APIs, and amino acid building blocks to pharmaceutical companies. It also provides research and development, custom synthesis, technology and equipment, special technology, regulatory affair, and good manufacturing practice services. The company specializes in the manufacturing of generic and innovative Active Pharmaceutical Ingredients (APIs) and also has a significant custom manufacturing business. They claim to have a 20 year history of successful FDA inspections.
#8
Funding Raised · Laupheim, Baden Wurttemberg · founded 1927 · 861 employees—raised▾
Rentschler Biopharma is a full-service contract development and manufacturing organization (CDMO) focused on the development and manufacturing of biopharmaceuticals. The company offers bioprocess development, biomanufacturing & associated consulting services. The bioprocess development services include cell line, process, formulation & analytical development. It has a proprietary technology platform TurboCell™ for mammalian cell line development. It has cGMP facility for biomanufacturing services. Also offers regulatory support & project management services related to biopharmaceutical development. It has strategic partnerships with Leukocare AG & Rentschler Fill Solutions to offer various CDMO services to the clients. The company has experience and expertise in the development of interferons, antibodies, fusion proteins and enzymes.
#9
Funding Raised · Ravensburg, Baden Wurttemberg · founded 1950 · 6000 employees—raised▾
Vetter is a global leader in the fill and finish of aseptically prefilled syringe systems, cartridges, and vials. Headquartered in Ravensburg, Germany, with production facilities in Germany and the United States, the contract development and manufacturing organization (CDMO) is an innovative solution provider serving the top 10 (bio-)pharmaceutical companies, as well as small and midsize companies. Its portfolio spans state-of-the-art manufacturing from early clinical development through commercial filling and final packaging of parenteral drugs. The company’s extensive experience covers a broad range of complex compounds including monoclonal antibodies, peptides, and interferons. Vetter supports its customers every step of the way, guiding their products through development, regulatory approval, launch and lifecycle management. The CDMO is also committed to patient safety and compliance with user-friendly solutions such as Vetter-Ject®, as well as its dual-chamber syringe Vetter Lyo-Ject® and cartridge system V-LK®. Vetter’s branch office in Singapore and its subsidiary in Tokyo, Japan, increase the presence of the company and the awareness of its service portfolio in the Asian he
#10
Deadpooled · Freiburg im Breisgau, Baden Wurttemberg · founded 2001 · 51 employees—raised▾
Provider of data management, medical writing and consulting services to biopharma
- Nov 2010Grant (prize money)—
Funding & investor landscape
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4872
- BASF Plant Science3982
- BASF SE3543
- Boehringer Ingelheim INT3438
- Merck Patent3133
- MAX Planck Gesellschaft1799
- Evonik Degussa1680
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.